Advanced Search

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    F 108.39 0.24% 0.26
    BNTX closed up 3.85 percent on Friday, June 2, 2023, on 1.25 times normal volume.
    10 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.24%
    Gapped Up Strength 0.24%
    NR7 Range Contraction 4.10%
    NR7-2 Range Contraction 4.10%
    Narrow Range Bar Range Contraction 4.10%
    Stochastic Reached Oversold Weakness 4.10%
    Oversold Stochastic Weakness 4.10%
    Calm After Storm Range Contraction 3.15%
    NR7 Range Contraction 3.15%
    NR7-2 Range Contraction 3.15%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    10 DMA Resistance about 2 hours ago
    Fell Below 10 DMA about 2 hours ago
    10 DMA Support about 3 hours ago
    2x Volume Pace 3 days ago
    1.5x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Allergy Biomarkers In Vitro Autoimmunity Immune Disorders Autoimmune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device In Vitro Diagnostic Devices

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 2 Why Shares of BioNTech Rose Friday
    Jun 2 BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment
    Jun 2 BioNTech reports promising data on BNT316, Phase 3 trial slated for Q3
    Jun 2 UPDATE 1-BioNTech's OncoC4 partnership off to good start with mid-stage trial results
    Jun 2 BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
    Jun 1 The Latest Analyst Ratings for BioNTech
    May 31 Heard on the Street: Investors Are Too Bearish on Vaccine-Makers
    May 31 Vaccine Fatigue Can Give Your Portfolio a Booster
    May 30 Next set of COVID boosters to target new Omicron variants – WSJ
    May 29 EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 188.985
    52 Week Low 100.81
    Average Volume 742,568
    200-Day Moving Average 138.20
    50-Day Moving Average 115.46
    20-Day Moving Average 106.61
    10-Day Moving Average 107.71
    Average True Range 3.87
    RSI (14) 47.37
    ADX 19.33
    +DI 32.88
    -DI 23.41
    Chandelier Exit (Long, 3 ATRs) 107.39
    Chandelier Exit (Short, 3 ATRs) 112.42
    Upper Bollinger Bands 112.74
    Lower Bollinger Band 100.48
    Percent B (%b) 0.62
    BandWidth 11.50
    MACD Line -2.40
    MACD Signal Line -2.94
    MACD Histogram 0.5468
    Fundamentals Value
    Market Cap 26.04 Billion
    Num Shares 241 Million
    EPS -0.56
    Price-to-Earnings (P/E) Ratio -192.03
    Price-to-Sales 143.59
    Price-to-Book 25.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 112.71
    Resistance 3 (R3) 112.70 111.15 111.95
    Resistance 2 (R2) 111.15 109.99 111.16 111.69
    Resistance 1 (R1) 109.64 109.27 110.40 109.66 111.44
    Pivot Point 108.10 108.10 108.48 108.11 108.10
    Support 1 (S1) 106.59 106.93 107.34 106.60 104.82
    Support 2 (S2) 105.04 106.21 105.05 104.57
    Support 3 (S3) 103.53 105.04 104.31
    Support 4 (S4) 103.55